Modular handheld imaging device

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a front, left-side perspective view of a modular handheld imaging device showing our new design.

FIG. 2 is a back, right-side perspective view thereof.

FIG. 3 is a front view thereof.

FIG. 4 is a back view thereof.

FIG. 5 is a left-side view thereof.

FIG. 6 is a right-side view thereof.

FIG. 7 is a top view thereof; and,

FIG. 8 is a bottom view thereof.

The portions of the figures depicted in broken lines are not part of the claimed design.

Claims

The ornamental design for a modular handheld imaging device as shown and described.

Referenced Cited
U.S. Patent Documents
3945371 March 23, 1976 Adelman
D389917 January 27, 1998 Hornback
D414867 October 5, 1999 Moriwaki et al.
5971918 October 26, 1999 Zanger
6190309 February 20, 2001 Ooshima et al.
6393315 May 21, 2002 Aprahamian et al.
6571119 May 27, 2003 Hayashi
6601997 August 5, 2003 Ngo
D480478 October 7, 2003 Leonard et al.
6678398 January 13, 2004 Wolters et al.
6889075 May 3, 2005 Marchitto et al.
D515214 February 14, 2006 Jackson, III et al.
D542820 May 15, 2007 Depay
D548347 August 7, 2007 Ichino
D569378 May 20, 2008 Wanamaker
D573044 July 15, 2008 Kalis
D585554 January 27, 2009 Suzuki
D594356 June 16, 2009 Riddiford
D605759 December 8, 2009 Cuevas et al.
D610178 February 16, 2010 Adolfsson et al.
D613411 April 6, 2010 Collins
7846091 December 7, 2010 Fulghum
D636424 April 19, 2011 Lin
D658298 April 24, 2012 Prpa
D677793 March 12, 2013 Prpa
8620410 December 31, 2013 Frangioni
D698937 February 4, 2014 Laverack et al.
D701606 March 25, 2014 Ohmukai
D703331 April 22, 2014 Kitayama
D703333 April 22, 2014 Saeki
D724234 March 10, 2015 Hagege
9042967 May 26, 2015 Dacosta et al.
D733595 July 7, 2015 Hoshino
D747391 January 12, 2016 Sakai
D748808 February 2, 2016 Matsumura et al.
D750260 February 23, 2016 Sauer
D753308 April 5, 2016 Marinkovich et al.
D755062 May 3, 2016 Yarden
9326666 May 3, 2016 Frangioni
9340490 May 17, 2016 Okura et al.
9451882 September 27, 2016 Nie et al.
D787684 May 23, 2017 Vezina
9743836 August 29, 2017 Tsubouchi et al.
D802777 November 14, 2017 Burachynsky et al.
D810293 February 13, 2018 Peel
D820987 June 19, 2018 Tam et al.
D822747 July 10, 2018 Van Deusen et al.
D822748 July 10, 2018 Van Deusen et al.
D825061 August 7, 2018 Parsons
D827014 August 28, 2018 Sakai
D835271 December 4, 2018 Myers et al.
D849105 May 21, 2019 Hogstedt et al.
D850628 June 4, 2019 De Hoog et al.
D859498 September 10, 2019 Lin
D861176 September 24, 2019 Yoon et al.
D861764 October 1, 2019 Zhao
D862697 October 8, 2019 Kenworthy et al.
10438356 October 8, 2019 Dacosta
D865836 November 5, 2019 Puusaari
D865845 November 5, 2019 Sakai
D866764 November 12, 2019 Pukall
D868867 December 3, 2019 Jean et al.
D873890 January 28, 2020 Fidler
D884175 May 12, 2020 Aubailly et al.
D897535 September 29, 2020 Rainville
D907097 January 5, 2021 Suurmeijer
D908161 January 19, 2021 Dacosta
D908881 January 26, 2021 Dacosta et al.
D910105 February 9, 2021 Lin
D910182 February 9, 2021 Dacosta et al.
D913354 March 16, 2021 Marzette, Jr. et al.
D914220 March 23, 2021 Nelson et al.
D916294 April 13, 2021 Murray et al.
D919093 May 11, 2021 Takahashi
D919690 May 18, 2021 Suurmeijer et al.
D921736 June 8, 2021 Yin
D921899 June 8, 2021 Suarez et al.
D922469 June 15, 2021 Sjogren et al.
D924306 July 6, 2021 Melnicoff
D930845 September 14, 2021 Schmidt et al.
D936827 November 23, 2021 Wang
D951456 May 10, 2022 Ooshima
D952023 May 17, 2022 Dacosta
D958991 July 26, 2022 Dacosta et al.
D959666 August 2, 2022 Dacosta et al.
D967420 October 18, 2022 Sun
D967433 October 18, 2022 Ai-Ali
D1042439 September 17, 2024 Brockhaus
D1066672 March 11, 2025 Al-Ali
12245840 March 11, 2025 Dacosta et al.
20010049473 December 6, 2001 Hayashi
20020150352 October 17, 2002 Ngo
20030191368 October 9, 2003 Wang et al.
20040225222 November 11, 2004 Zeng et al.
20050029437 February 10, 2005 Hasegawa et al.
20050234526 October 20, 2005 Gilhuly et al.
20050288594 December 29, 2005 Lewkowicz et al.
20060004292 January 5, 2006 Beylin
20060241493 October 26, 2006 Feldman et al.
20080059070 March 6, 2008 Boyden et al.
20080108869 May 8, 2008 Sanders et al.
20080188758 August 7, 2008 Campbell et al.
20090137908 May 28, 2009 Patwardhan
20100084563 April 8, 2010 Ohno
20100145146 June 10, 2010 Melder
20100145419 June 10, 2010 Fraval
20100292580 November 18, 2010 Gilhuly et al.
20110117025 May 19, 2011 Dacosta et al.
20110275900 November 10, 2011 Gilhuly et al.
20110305422 December 15, 2011 Thompson et al.
20120016230 January 19, 2012 Kishima et al.
20120101390 April 26, 2012 Iftimia et al.
20120165627 June 28, 2012 Yamamoto
20120323124 December 20, 2012 Corbett, III et al.
20130338479 December 19, 2013 Pogue et al.
20140180116 June 26, 2014 Lindekugel et al.
20140275772 September 18, 2014 Chuda
20140276102 September 18, 2014 Lee et al.
20140276103 September 18, 2014 Lee et al.
20150030542 January 29, 2015 Singhal
20150038837 February 5, 2015 Inoue et al.
20150150460 June 4, 2015 Krishnaswamy et al.
20150182118 July 2, 2015 Bradbury et al.
20150182196 July 2, 2015 Ninomiya et al.
20150198797 July 16, 2015 Andre et al.
20150230696 August 20, 2015 Tuch et al.
20160045114 February 18, 2016 Dacosta et al.
20160062103 March 3, 2016 Yang et al.
20160206202 July 21, 2016 Frangioni
20160287194 October 6, 2016 Nariyuki et al.
20160287211 October 6, 2016 DaCosta et al.
20170000320 January 5, 2017 Wilson et al.
20170085855 March 23, 2017 Roberts et al.
20170143418 May 25, 2017 Lee
20170156597 June 8, 2017 Whitehead
20170209050 July 27, 2017 Fengler et al.
20170235118 August 17, 2017 Kuster et al.
20170236281 August 17, 2017 Dacosta
20170280969 October 5, 2017 Levy et al.
20170290515 October 12, 2017 Butte et al.
20170325698 November 16, 2017 Allec et al.
20180014764 January 18, 2018 Bechtel et al.
20180070806 March 15, 2018 Matsuo et al.
20180098741 April 12, 2018 Lu et al.
20180133320 May 17, 2018 Babic et al.
20180206739 July 26, 2018 Forero Cortes et al.
20180218508 August 2, 2018 Lee et al.
20180234603 August 16, 2018 Moore et al.
20180242848 August 30, 2018 Dacosta et al.
20180252909 September 6, 2018 Regensburger et al.
20180276814 September 27, 2018 Frangioni
20180279864 October 4, 2018 Frangioni
20180310829 November 1, 2018 Frangioni et al.
20180325377 November 15, 2018 Dacosta et al.
20180369603 December 27, 2018 Gjersvik et al.
20190079011 March 14, 2019 Frangioni
20190159663 May 30, 2019 Krstajie et al.
20190209000 July 11, 2019 Treado et al.
20190216325 July 18, 2019 Ouyang
20200128166 April 23, 2020 Fukumoto
20200188033 June 18, 2020 Komp et al.
20200359884 November 19, 2020 Swisher
20210228300 July 29, 2021 DaCosta et al.
20210378584 December 9, 2021 Takahashi et al.
20220007942 January 13, 2022 Stith et al.
20220061671 March 3, 2022 Dacosta
20220071559 March 10, 2022 Jones et al.
20220072294 March 10, 2022 Locke et al.
20220248944 August 11, 2022 Dacosta et al.
20230165469 June 1, 2023 Kirman
20240265544 August 8, 2024 Hirson
Foreign Patent Documents
2014373656 July 2016 AU
208795 March 2022 CA
101208037 June 2008 CN
103654699 March 2014 CN
104271046 January 2015 CN
104394754 March 2015 CN
105212880 January 2016 CN
106714670 May 2017 CN
106983495 July 2017 CN
107093171 August 2017 CN
304554755 March 2018 CN
108289723 July 2018 CN
B06141139 October 2020 CN
307182522 September 2022 CN
307545922 September 2022 CN
307713119 December 2022 CN
006624763-0002 July 2019 EM
1880660 January 2008 EP
2502551 September 2012 EP
3372143 September 2018 EP
4284131 November 2023 EP
H08224208 September 1996 JP
H09-000488 January 1997 JP
H10151104 June 1998 JP
2003190091 July 2003 JP
2004305367 November 2004 JP
2005124776 May 2005 JP
2006509573 March 2006 JP
2006166940 June 2006 JP
2006340796 December 2006 JP
2007244746 September 2007 JP
2009045148 March 2009 JP
2009066121 April 2009 JP
2011521237 July 2011 JP
2012532689 December 2012 JP
2013514156 April 2013 JP
2013123647 June 2013 JP
2013531538 August 2013 JP
2015139613 August 2015 JP
2016030214 March 2016 JP
2016-520339 July 2016 JP
2017060778 March 2017 JP
2017524935 August 2017 JP
2017192501 October 2017 JP
2024-160225 November 2024 JP
7648525 March 2025 JP
10-1503891 March 2015 KR
300827516.0000 November 2015 KR
10-2016-0065258 June 2016 KR
2010080611 July 2010 WO
2013184830 December 2013 WO
2016011534 January 2016 WO
2016063949 April 2016 WO
2017079844 May 2017 WO
2017082242 May 2017 WO
2017096137 June 2017 WO
2018145193 August 2018 WO
2019148268 August 2019 WO
20190213737 November 2019 WO
2020148724 July 2020 WO
2020148725 July 2020 WO
2020148726 July 2020 WO
Other references
  • Launch of New MolecuLightDX™ Device, Oct. 14, 2021, [retrieved Oct. 16, 2025], Retrieved from Internet, URL: <https://moleculight.com/news/launch-of-new-moleculightdx-device-to-enable-point-of-care-imaging-of-wounds-in-new-expanding-market-segments/#:˜:text=PRESS> (Year: 2021).
  • Launch of New MolecuLightDX™ Device, Oct. 14, 2021, [retrieved Oct. 16, 2025], Retrieved from Internet, URL: <https://www.prnewswire.com/news-releases/launch-of-new-moleculightdx-device-to-enable-point-of-care-imaging-of-wounds-in-new-expanding-market-segments-301400063.html> (Year: 2021).
  • MolecuLight launches DX device, Oct. 15, 2021, [retrieved Oct. 16, 2025], Retrieved from Internet, URL: <https://vascularnews.com/moleculight-launces-dx-device/> (Year: 2021).
  • MolecuLight secures group purchasing deal, Sep. 30, 2022, [retrieved Oct. 16, 2025], Retrieved from Internet, URL: <https://www.medicaldevice-network.com/news/moleculight-wound-imaging/> (Year: 2022).
  • Office Action dated May 23, 2024 in MX Application No. MX/f/2022/000423.
  • Notice of Grant dated Jun. 11, 2024 in JP Application No. 2021-541486.
  • Notice of Allowance dated May 27, 2024 in MX/f/2024/000967.
  • Notice of Allowance dated May 27, 2024 in MX/f/2024/000968.
  • Office Action dated Jul. 16, 2024 received in JP Application No. 2021-541493.
  • Office Action dated Jul. 16, 2024 received in JP Application No. 2021-541474.
  • Notice of Allowance dated Jun. 11, 2024 in CA Application No. 3, 127,048.
  • Office Action dated Jun. 28, 2024 received in CN Application No. 2019800233835.
  • Office Action dated Jul. 4, 2024 received in CN Application No. 2020800191924.
  • U.S. Appl. No. 62/793,842, dated Jan. 17, 2019.
  • U.S. Appl. No. 62/793,846, dated Jan. 17, 2019.
  • U.S. Appl. No. 62/857,183, dated Jun. 4, 2019.
  • Design U.S. Appl. No. 29/676,901, dated Jan. 15, 2019.
  • Design U.S. Appl. No. 29/677,152, dated Jan. 17, 2019.
  • International Search Report and Written Opinion from International Patent Application No. PCT/CA2019/000015, dated Jun. 4, 2019.
  • “Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy”, 2017, Gao et al. https://www.researchgate.net/publication/315469453 Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy.
  • “Current concepts and future perspectives on surgical optical imaging in cancer”,2010, Ntziachristos et al , https://www.sniedigitallibrary.orMoumals/Jounial-of-Biomedical-Onticstvolume-15issue-61066024/Current-concepts-and-future-perspectives-on-surgical-optical-imaging-in/10.1117/1.3523364.full7SSO=I.
  • Notice of Allowance in Design U.S. Appl. No. 29/677,154, dated Apr. 1, 2020.
  • Notice of Allowance in Design U.S. Appl. No. 29/677,152, dated Apr. 1, 2020.
  • Ex Parte Quayle Action in Design U.S. Appl. No. 29/676,901, dated Mar. 5, 2020.
  • Notice of Allowance in Design U.S. Appl. No. 29/676,901, dated Jun. 4, 2020.
  • International Search Report and Written Opinion from International Patent Application No. PCT/IB2020/050384 dated Apr. 22, 2020.
  • International Patent Application No. PCT/IB2020/050384, dated Jan. 17, 2020.
  • International Patent Application No. PCT/IB2020/050383, dated Jan. 17, 2020.
  • International Patent Application No. PCT/IB2020/050385, dated Jan. 17, 2020.
  • International Search Report and Written Opinion from International Patent Application No. PCT/IB2020/050385 dated Apr. 8, 2020.
  • Notice of Allowance in Design U.S. Appl. No. 29/677,152, dated Sep. 22, 2020.
  • Notice of Allowance in Design U.S. Appl. No. 29/676,901, dated Sep. 18, 2020.
  • Ex Parte Quayle Action in Design U.S. Appl. No. 29/677,152, dated Dec. 20, 2019.
  • Design U.S. Appl. No. 29/762,417, dated Dec. 16, 2020.
  • Design U.S. Appl. No. 29/767,502, dated Jan. 22, 2021.
  • U.S. Appl. No. 17/423,447, dated Jul. 15, 2021.
  • U.S. Appl. No. 17/423,576, dated Jul. 16, 2021.
  • U.S. Appl. No. 17/423,609, dated Jul. 16, 2021.
  • Office Action dated Aug. 17, 2021 in related U.S. Appl. No. 29/762,417, 9 pages.
  • European Search Report for EP Application No. EP19746801 dated Sep. 13, 2021, 2 pages.
  • “Nagaya et al Fluorescence-Guided Surgery”, Frontiers in Oncology, vol. 7, Dec. 22, 2017, 16 pp.
  • Notice of Allowance in Design U.S. Appl. No. 29/762,417, dated Jan. 13, 2022, 13 pages.
  • Notice of Allowance in Design U.S. Appl. No. 29/767,502 dated Mar. 11, 2022, 5 pages.
  • Notice of Allowance in U.S. Appl. No. 29/767,874 dated Mar. 21, 2022.
  • Examination Report dated Mar. 24, 2022 in IN App No. 358348-001.
  • Examination Report dated Mar. 24, 2022 in IN App No. 358347-001.
  • Supplementary Partial European Search report dated Sep. 20, 2022 in related EP Application No. 20740856.8, 12 pages.
  • Supplementary European Search report dated Sep. 20, 2022 in related EP Application No. 20741034.1, 27 pages.
  • Supplementary European Search report dated Sep. 26, 2022 in related EP Application No. 20741678.5, 9 pages.
  • Office Action dated Sep. 16, 2022 in related CA Application No. 3,127,036.
  • Notice of Allowance dated Sep. 27, 2022 in related JP Application No. 2022-003401.
  • Office Action dated Oct. 6, 2022 in related CA Application No. 3,127,048.
  • 7 Office Action dated Sep. 27, 2022 in related JP Application No. 2022-019073.
  • European Search report dated Jan. 5, 2023 in related EP Application No. 20740856.8.
  • First Examination report dated Feb. 3, 2023 in related IN App No. 202117030136.
  • Office Action dated Sep. 2, 2024 received in EP Application No. 19746801.0.
  • Office Action dated Sep. 3, 2024 received in JP Application No. 2023-199730.
  • Office Action dated Jul. 25, 2024 in MX Application No. MX/a/2021/008504.
  • Examination Report dated Sep. 6, 2024 received in AU Application No. 2020209518.
  • Examination Report dated Sep. 5, 2024 received in AU Application No. 2020209276.
  • Office Action dated Aug. 6, 2024 received in CN Application No. 2020800219686.
  • Notice of Allowance dated Jan. 20, 2025 received in MX Application No. MX/a/2021/008504.
  • Notice of Grant dated Feb. 4, 2025 in JP Application No. 2021-541474.
  • Office Action dated Feb. 4, 2025 received in JP Application No. 2021-541493.
  • Office Action dated Feb. 12, 2025 in JP Application No. 2020-541946.
  • Office Action dated Jan. 1, 2025 received in JP Application No. 2020800219686.
  • Notice of Allowance dated Feb. 24, 2025 received in MX Application No. MX/a/2020/008159.
  • Office Action dated Feb. 12, 2025 in CN Application No. 2020800191924.
  • Office Action dated Mar. 11, 2025 in JP Application No. 2023-199730.
  • Masafumi Oyama et al., “Application of PDD to renal cell carcinoma”, Japanese Journal of Endourology, vol. 24, Japanese Society of Endourology and Robotics, 2011, p. 23-28, URL:https://www.j stage.j st.go.jp/ article/j sejj e/24/1/24_23 /_pdf.
  • Office Action dated Mar. 14, 2025 in CA Application No. 3,090,190.
  • SnapshotNIR, www.woundsource.com, Jan. 25, 2017, URL:https://www.bing.com/images/search?view=detailV2&ccid=2SJ6i4ko&id=C2EDCF8F23663F9D7A426C6045D60816D88E820D&thid.
  • U.S. Appl. No. 29/842,182 filed Jun. 10, 2022.
  • U.S. Appl. No. 29/842,512, filed Jun. 14, 2022.
  • Office Action dated Jun. 21, 2022 in family member Brazilian Application No. BR 302022000890-7.
  • Office Action dated Jul. 13, 2023 in CA Application No. 3,127,048.
  • Decision Of Rejection dated Jul. 25, 2023 in JP Application No. 2020-541946.
  • Office Action dated Jul. 14, 2023 in CA Application No. 3, 127,036.
  • Notification of the First Rectification dated Jul. 5, 2023 in CN Application No. 2022300861326.
  • Office Action dated Jun. 20, 2023 received in JP Application No. 2023-003578.
  • Examination Report dated Aug. 10, 2023 in CA Application No. 210515.
  • Office Action dated Oct. 3, 2023 received in Design U.S. Appl. No. 29/842,512, 8 pages.
  • BayCare, Lumicell, Inc. Selects BayCare for Pivotal Breast Cancer Trial, Published on: Oct. 9, 2020, Baycare.org, Retrieved from Internet: https://baycare.org/newsroom/2020/october/lumicell-inc-selects-baycare-for-pivotal-breast-cancer-clinical-trial (Year: 2020).
  • Office Action dated Oct. 3, 2023 received in JP Application No. 2021-541493.
  • Office Action dated Oct. 3, 2023 received in JP Application No. 2021-541474.
  • Notice of Allowance dated Oct. 13, 2023 in Design U.S. Appl. No. 29/842,182, 9 pages.
  • Advanced Endoscopy Devices, Inc, Introducing the Multi-Disciplinary Use of the Aed Endopro-Cam® Elite, Uploaded on: Mar. 11, 2020, YouTube, Retrieved from Internet: https://www.youtube.com/watch?v=rnxtMz2JhFg (Year: 2020).
  • SBI ALAPharma, The Eagle V1.2 Imaging System, Downloaded on: Aug. 22, 2023, sbi-alapharmacanada.ca, Retrieved from Internet: https://www.sbi-alapharmacanada.ca/technology (Year: 2023).
  • Action dated Nov. 7, 2023 received in JP Patent Application No. 2021-541486.
  • Action dated Sep. 27, 2023 received in CN Patent Application No. 2020800191924.
  • Action dated Nov. 4, 2023 received in CA Patent Application No. 225,390.
  • Office Action dated Sep. 28, 2023 received in CN Patent Application No. 2019800233835.
  • Examination report dated Nov. 30, 2023 received in AU Patent Application No. 2019215811.
  • European Search Report dated Jan. 12, 2024 received in EP Patent Application No. 23188747.2.
  • Office Action dated Jan. 17, 2024 in CN Patent Application No. 2020800184047.
  • Office Action dated Jan. 24, 2024 in U.S. Appl. No. 16/966,293, 18 pp.
  • Office Action dated Oct. 12, 2023 in CN Patent Application No. 2020800219686.
  • Office Action dated Jan. 11, 2024 in CN Patent Application No. 2022300861326.
  • Notice of Allowance dated Feb. 5, 2024 in Design U.S. Appl. No. 29/842,512.
  • Office Action dated Feb. 20, 2024 in U.S. Appl. No. 17/423,447, 25 pp.
  • Office Action dated Feb. 22, 2024 in U.S. Appl. No. 17/423,576, 26 pp.
  • Office Action dated Jan. 26, 2024 in MX Patent Application No. MX/f/2022/000423.
  • Office Action dated Mar. 27, 2024 in CA Application No. 3,127,039.
  • Office Action dated Mar. 28, 2024 in CA Application No. 3,090,190.
  • Office Action dated Apr. 3, 2024 in CN Application No. 2019800233835.
  • Office Action dated Nov. 20, 2024 received in MX Application No. MX/a/2020/008159.
  • Notice of Issuance dated Nov. 22, 2024 in CN Application No. 2024301422414.
  • Office Action dated Oct. 24, 2024 in Canadian Application No. 3,127,036.
  • Corrected Notice of Allowability dated Jan. 8, 2025 received in U.S. Appl. No. 17/423,447.
  • Office Action dated Apr. 4, 2023 received in related JP Application No. 2020-541946.
  • Written Opinion dated Apr. 21, 2023 in related Application No. 11202107275Q.
  • Office Action dated Sep. 26, 2024 in U.S. Appl. No. 17/423,609, 52 pp.
  • Examination Report dated Sep. 27, 2024 received in AU Application No. 2020208843.
  • Notice of Allowance dated Oct. 30, 2024 received in U.S. Appl. No. 17/423,447, 7 pp.
  • Office Action dated Oct. 16, 2024 received in CN Application No. 2019800233835.
  • Final Office Action dated Nov. 1, 2024 received in U.S. Appl. No. 17/423,576, 22 pages.
  • Final Office Action dated Nov. 7, 2024 received in U.S. Appl. No. 16/966,293, 21 pp.
  • Office Action dated Nov. 14, 2024 received in Korean Application No. 10-2021-7026033.
  • Corrected Notice of Allowability dated Nov. 27, 2024 received in U.S. Appl. No. 17/423,447.
  • Office Action dated Oct. 17, 2024 received in CN Application No. 2020800184047.
  • Office Action dated Apr. 22, 2024 received in MX Application No. MX/a/2020/008159.
  • First Examination report dated Jun. 30, 2022 in related IN App No. 202017037681.
  • Application and Drawings filed Mar. 10, 2025 in U.S. Appl. No. 19/075,323.
  • Notice of Issuance dated May 19, 2025 in CN Application No. 2020800184047.
  • Office Action dated Jun. 5, 2025 in EP Application No. 20741034.1.
  • Office Action dated Jun. 13, 2025 received in U.S. Appl. No. 17/423,576, 18 pages.
  • Notice of Allowance dated Jul. 1, 2025 for U.S. Appl. No. 17/423,609.
  • Office Action dated Jul. 18, 2025 in CA Application No. 3,127,039.
  • Office Action dated Jul. 23, 2025 received in KR Application No. 10-2021-7026039.
  • Office Action dated Jul. 29, 2025 received in JP Application No. 2024-110804.
  • Office Action dated Aug. 13, 2025 received in U.S. Appl. No. 16/966,293, 25 pages.
Patent History
Patent number: D1117133
Type: Grant
Filed: Aug 23, 2021
Date of Patent: Mar 10, 2026
Assignee: MOLECULIGHT INC. (Toronto)
Inventors: Nikola Andric (Toronto), Danielle Dunham (Scarborough), Desmond Hirson (North York), Nitesh Mistry (Toronto), Simon Treadwell (Toronto)
Primary Examiner: Messina L Smith
Assistant Examiner: Aram Kwon
Application Number: 29/804,808
Classifications
Current U.S. Class: Equipment For Diagnosis, Analysis, Or Treatment (D24/107)